L. Déroulement-de, 18 2.2.1. Première consultation : prise de la mifepristone, .

C. Fiala and K. Gemzel-danielsson, Review of medical abortion using mifepristone in combination with a prostaglandin analogue, Contraception, vol.74, issue.1, pp.66-86, 2006.
DOI : 10.1016/j.contraception.2006.03.018

M. Mazuy, L. Toulemon, E. Baril-raymond, E. Shannon, C. Weaver et al., Un recours moindre à l'IVG, mais plus souvent répété. Populations & Sociétés HAS-Haute Autorité de Santé. Recommandations de bonne pratique: Interruption volontaire de grossesse par méthode médicamenteuse First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review, BIBLIOGRAPHIE 1. Vilain Annick. Les interruptions volontaires de grossesse en 2012, 2010.

R. Kulier, N. Kapp, A. Gülmezoglu, G. Hofmeyr, L. Cheng et al., Medical methods for first trimester abortion, Cochrane Database Syst Rev, issue.11, p.2855, 2011.

E. Schaff, S. Fielding, S. Eisinger, L. Stadalius, and L. Fuller, Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days, Contraception, vol.61, issue.1, 2000.
DOI : 10.1016/S0010-7824(99)00119-5

A. Aronsson, M. Bygdeman, and K. Gemzell-danielsson, Effects of misoprostol on uterine contractility following different routes of administration, Human Reproduction, vol.19, issue.1, 2004.
DOI : 10.1093/humrep/deh005

P. Dolley, G. Carles, F. Salaun, I. Asselin, and M. Dreyfus, CNGOF. Etat des lieux et expertise de l'usage hors AMM du misoprostol en gynécologie-obstétrique: travail du CNGOF [Misoprostol: offlabel use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)], J Gynécologie Obstétrique Biol Reprod Feb, vol.1943, issue.12, pp.81-85, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01482637

I. Spitz, C. Bardin, L. Benton, and A. Robbins, Early Pregnancy Termination with Mifepristone and Misoprostol in the United States, New England Journal of Medicine, vol.338, issue.18, pp.1241-1248, 1998.
DOI : 10.1056/NEJM199804303381801

E. Schaff, S. Fielding, and C. Westhoff, Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy, Contraception, vol.66, issue.4, pp.247-50, 2002.
DOI : 10.1016/S0010-7824(02)00366-9

B. Winikoff, I. Dzuba, M. Creinin, W. Crowden, A. Goldberg et al., Two Distinct Oral Routes of Misoprostol in Mifepristone Medical Abortion, Eur J Contracept Reprod Health Care Off J Eur Soc Contracept, pp.1303-1313, 2008.
DOI : 10.1097/AOG.0b013e31818d8eb4

S. Raghavan, R. Comendant, I. Digol, S. Ungureanu, V. Friptu et al., Twopill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol, Contraception, 2009.

F. Tang, O. Chan, C. Ng, E. Lee, S. Ho et al., A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation, Human Reproduction, vol.18, issue.11, pp.84-90, 2003.
DOI : 10.1093/humrep/deg475

P. Ashok, A. Templeton, P. Wagaarachchi, and G. Flett, Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases, BJOG: An International Journal of Obstetrics and Gynaecology, vol.99, issue.2, pp.1281-1290, 2002.
DOI : 10.1016/S0010-7824(00)00090-1

K. Danielsson, WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy, BJOG Int J Obstet Gynaecol, 2003.

M. Reeves, M. Fox, P. Lohr, and M. Creinin, Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention, Ultrasound in Obstetrics and Gynecology, vol.114, issue.1, pp.104-113, 2009.
DOI : 10.1002/uog.6404

J. Russo, T. Depiñeres, and L. Gil, Controversies in family planning: retained products of conception, Contraception, vol.86, issue.5, pp.438-480, 2012.
DOI : 10.1016/j.contraception.2012.04.003

A. Cowett, L. Cohen, E. Lichtenberg, C. Stika, A. Kamaya et al., Ultrasound evaluation of the endometrium after medical termination of pregnancy Retained products of conception: spectrum of color Doppler findings, Obstet Gynecol J Ultrasound Med Off J Am Inst Ultrasound Med, vol.103528, issue.18, pp.871-876, 2004.

M. Sellmyer, T. Desser, K. Maturen, R. Jeffrey, and A. Kamaya, Physiologic, Histologic, and Imaging Features of Retained Products of Conception, RadioGraphics, vol.33, issue.3, pp.781-96
DOI : 10.1148/rg.333125177

S. Gaudu, M. Crost, and L. Esterle, Results of a 4-year study on 15,447 medical abortions provided by privately practicing general practitioners and gynecologists in France, Contraception, vol.87, issue.1, pp.45-50, 2013.
DOI : 10.1016/j.contraception.2012.06.006

C. Fiala, P. Safar, M. Bygdeman, and K. Gemzell-danielsson, Verifying the effectiveness of medical abortion; ultrasound versus hCG testing, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.109, issue.2, 2003.
DOI : 10.1016/S0301-2115(03)00012-5

W. Clark, M. Gold, D. Grossman, and B. Winikoff, Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research. Contraception, 2007.

E. Horning, B. Chen, L. Meyn, and M. Creinin, Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment, Contraception, vol.85, issue.4, pp.402-409
DOI : 10.1016/j.contraception.2011.09.007

W. Clark, H. Bracken, J. Tanenhaus, S. Schweikert, E. Lichtenberg et al., Alternatives to a routine follow-up visit for early medical abortion, Obstet Gynecol, 2010.

C. Rørbye, M. Nørgaard, V. Vestermark, and L. Nilas, Medical abortion, Contraception, vol.68, issue.4, pp.247-51, 2003.
DOI : 10.1016/S0010-7824(03)00175-6

J. Amer-alshiek, O. Shiekh, A. Agmon, and D. Grisaru, What is the right timing for ultrasound evaluation after pregnancy termination with mifepristone?, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.189, pp.24-30
DOI : 10.1016/j.ejogrb.2015.03.018

J. Pauleta, N. Clode, and G. , Expectant management of incomplete abortion in the first trimester, International Journal of Gynecology & Obstetrics, vol.17, issue.(6), pp.35-43, 2009.
DOI : 10.1016/j.ijgo.2009.02.018

M. Gatter, C. K. Nucatola, and D. , Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days, Contraception, vol.91, issue.4, pp.269-73
DOI : 10.1016/j.contraception.2015.01.005

J. Kahn, B. Becker, L. Macisaa, J. Amory, J. Neuhaus et al., The efficacy of medical abortion: a meta-analysis, Contraception, vol.61, issue.1, pp.29-40, 2000.
DOI : 10.1016/S0010-7824(99)00115-8

E. Schaff, S. Fielding, and C. Westhoff, Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception, 2001.

L. Wedisinghe and D. Elsandabesee, Flexible mifepristone and misoprostol administration interval for first-trimester medical termination, Contraception, vol.81, issue.4, pp.269-74, 2010.
DOI : 10.1016/j.contraception.2009.09.007

J. Bartley, S. Tong, D. Everington, and D. Baird, Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost, Contraception, vol.62, issue.6, pp.297-303, 2000.
DOI : 10.1016/S0010-7824(00)00187-6

K. Cleland, M. Creinin, D. Nucatola, M. Nshom, and J. Trussell, Significant Adverse Events and Outcomes After Medical Abortion, Obstetrics & Gynecology, vol.121, issue.1, pp.166-71, 2013.
DOI : 10.1097/AOG.0b013e3182755763

C. Shannon, L. Brothers, N. Philip, and B. Winikoff, Infection after medical abortion: A review of the literature, Contraception, vol.70, issue.3, pp.183-90, 2004.
DOI : 10.1016/j.contraception.2004.04.009

A. Cohen, J. Bhatnagar, S. Reagan, S. Zane, D. Angeli et al., Toxic Shock Associated With Clostridium sordellii and Clostridium perfringens After Medical and Spontaneous Abortion, Obstetrics & Gynecology, vol.110, issue.5, pp.1027-1060, 2007.
DOI : 10.1097/01.AOG.0000287291.19230.ba

M. Chassang, G. Baudin, J. Delotte, C. Trastour, A. Bongain et al., Role of imaging in cases of bleeding after spontaneous or induced abortion] Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review Bull World Health Organ, J Gynécologie Obstétrique Biol Reprod, vol.4489, issue.55, pp.398-402, 2011.